ArticleStem cells international2019

Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases.

Kuang Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.